About JenaValve Technology
JenaValve Technology is a company based in Irvine (United States) founded in 2006 was acquired by Edwards Lifesciences in July 2024.. JenaValve Technology has raised $363.7 million across 13 funding rounds from investors including Peijia Medical Technologies, Edwards Lifesciences and Edmond de Rothschild. The company has 198 employees as of December 31, 2023. JenaValve Technology offers products and services including Trilogy System and ALIGN-AR Study. JenaValve Technology operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Irvine, United States
- Employees 198 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$363.7 M (USD)
in 13 rounds
-
Latest Funding Round
$100 M (USD), Series C
Dec 21, 2021
-
Investors
Peijia Medical Technologies
& 18 more
-
Employee Count
198
as on Dec 31, 2023
-
Acquired by
Edwards Lifesciences
(Jul 25, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of JenaValve Technology
JenaValve Technology offers a comprehensive portfolio of products and services, including Trilogy System and ALIGN-AR Study. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for treating severe aortic regurgitation in high-risk patients.
Research evaluating safety and efficacy of Trilogy System.
Unlock access to complete
Unlock access to complete
Leadership Team
17 people
Software Development Team
13 people
Product Management Team
5 people
Operations Team
5 people
Senior Team
5 people
Principal Team
4 people
Sales and Marketing
3 people
Human Resources and Administration
3 people
Unlock access to complete
Funding Insights of JenaValve Technology
JenaValve Technology has successfully raised a total of $363.7M across 13 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series C — $100.0M
-
First Round
First Round
(22 Sep 2006)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series C - JenaValve Technology | Valuation | Bain Capital Life Sciences | |
| Jan, 2020 | Amount | Series C - JenaValve Technology | Valuation |
investors |
|
| Jun, 2019 | Amount | Series C - JenaValve Technology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in JenaValve Technology
JenaValve Technology has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Peijia Medical Technologies, Edwards Lifesciences and Edmond de Rothschild. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by JenaValve Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - JenaValve Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jenavalve Technology Comparisons
Competitors of JenaValve Technology
JenaValve Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| domain | founded_year | HQ Location |
Smart medical devices for heart valve diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jenavalve Technology
Frequently Asked Questions about JenaValve Technology
When was JenaValve Technology founded?
JenaValve Technology was founded in 2006.
Where is JenaValve Technology located?
JenaValve Technology is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Who is the current CEO of JenaValve Technology?
John Kilcoyne is the current CEO of JenaValve Technology.
Is JenaValve Technology a funded company?
JenaValve Technology is a funded company, having raised a total of $363.7M across 13 funding rounds to date. The company's 1st funding round was a Series C of $14.49M, raised on Sep 22, 2006.
How many employees does JenaValve Technology have?
As of Dec 31, 2023, the latest employee count at JenaValve Technology is 198.
What does JenaValve Technology do?
Provider of pericardial transcatheter aortic valve replacement and delivery system. It offers Trilogy Valve with locator technology that includes a root valve sewn onto a stent and a delivery system for the treatment of aortic valve stenosis for treatment of patients suffering from the aortic valve insufficiency.
Who are the top competitors of JenaValve Technology?
JenaValve Technology's top competitors include Shockwave Medical, Cardiac Dimensions and Peijia Medical Technologies.
What products or services does JenaValve Technology offer?
JenaValve Technology offers Trilogy System and ALIGN-AR Study.
Who are JenaValve Technology's investors?
JenaValve Technology has 19 investors. Key investors include Peijia Medical Technologies, Edwards Lifesciences, Edmond de Rothschild, Gimv, and Andera Partners.